- 全部删除
 
您的购物车当前为空
GSK2239633 is a potent CC-chemokine receptor 4 antagonist with pIC50 of 7.9. The CC-chemokine receptor 4 (CCR4) is thought potentially to play a critical role in asthma pathogenesis due to its ability to recruit type 2 T-helper lymphocytes to the inflamed airways. Therefore, CCR4 provides an excellent target for anti-inflammatory therapy.

GSK2239633 is a potent CC-chemokine receptor 4 antagonist with pIC50 of 7.9. The CC-chemokine receptor 4 (CCR4) is thought potentially to play a critical role in asthma pathogenesis due to its ability to recruit type 2 T-helper lymphocytes to the inflamed airways. Therefore, CCR4 provides an excellent target for anti-inflammatory therapy.
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 25 mg | ¥ 11,700  | 6-8周 | |
| 50 mg | ¥ 15,300  | 6-8周 | |
| 100 mg | ¥ 19,500  | 6-8周 | 
| 产品描述 | GSK2239633 is  a potent CC-chemokine receptor 4 antagonist with pIC50 of 7.9.  The CC-chemokine receptor 4 (CCR4) is thought potentially to play a critical role in asthma pathogenesis due to its ability to recruit type 2 T-helper lymphocytes to the inflamed airways. Therefore, CCR4 provides an excellent target for anti-inflammatory therapy.  | 
| 分子量 | 506.98 | 
| 分子式 | C21H19ClN4O5S2 | 
| CAS No. | 2181665-31-4 | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容